196 related articles for article (PubMed ID: 4677056)
21. [The pharmacology of glisoxepide, a new oral antidiabetic].
Puls W; Losert W; Loge O; Schillinger E; Keup U; Kroneberg G
Arzneimittelforschung; 1974 Mar; 24(0):375-92. PubMed ID: 4408136
[No Abstract] [Full Text] [Related]
22. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
Beyer J; Cordes U; Krall H; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
[No Abstract] [Full Text] [Related]
23. [Comparative use of gliquidone and tolbutamide administered intravenously].
Zilker T; Lüders L; Bottermann P
MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
[No Abstract] [Full Text] [Related]
24. Hypoglycaemic and related activities of a new pyrazolopyridine derivative (SQ 65,993).
Polacek I; Schulze E; Burg H; Ouart J
Arzneimittelforschung; 1974 Sep; 24(9):1242-7. PubMed ID: 4479785
[No Abstract] [Full Text] [Related]
25. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
[No Abstract] [Full Text] [Related]
26. [Pharmacology of HB 419, a new strongly effective oral antidiabetic].
Bänder A; Pfaff W; Schmidt FH; Stork H; Schröder HG
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1363-8. PubMed ID: 5394454
[No Abstract] [Full Text] [Related]
27. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
Artini D; Abbiati R; Orsini G; Parenti MA; Bloch K; Daturi S; Mandelli V
Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091
[No Abstract] [Full Text] [Related]
28. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
Beyer J; Cordes U; Sell G; Krall H; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
[No Abstract] [Full Text] [Related]
29. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
Marble A
Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
[No Abstract] [Full Text] [Related]
30. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
[No Abstract] [Full Text] [Related]
31. [Studies on the mechanism of action of sulfonylurea compounds. Effect of glibornuride and insulin on blood sugar, plasma catecholamines and on the immunologically determinable insulin following blockade of adrenergic receptors].
Cordes U; Beyer J; Sell G; Haupt E; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2164. PubMed ID: 4146790
[No Abstract] [Full Text] [Related]
32. [Studies on dose-response relationship of various sulfonylurea derivatives of the old and the new generation with further hints to extrapancreatic mechanisms of decreasing blood sugar].
Haupt E; Köberich W; Cordes U; Beyer J; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2203. PubMed ID: 4198968
[No Abstract] [Full Text] [Related]
33. [The blood-sugar depressing and betacytotrope effect of glibornurid in healthy and in gastric-resected persons (author's transl)].
Grabner W; Matzkies F; Randerbrock V; Berg G
Med Klin; 1973 Aug; 68(34):1101-5. PubMed ID: 4598149
[No Abstract] [Full Text] [Related]
34. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
35. Profile of insulin release due to intrapancreatic glyburide infusion.
Colwell AR; Zuckerman L
Diabetes; 1972 Apr; 21(4):209-15. PubMed ID: 4622788
[No Abstract] [Full Text] [Related]
36. Dynamics of insulin release and microtubular-microfilamentous system. IV. Effect of colchicine upon sulphonylurea-induced insulin secretion.
Van Obberghen E; Devis G; Somers G; Ravazzola M; Malaisse-Lagae F; Malaisse WJ
Eur J Clin Invest; 1974 Oct; 4(5):307-12. PubMed ID: 4426330
[No Abstract] [Full Text] [Related]
37. [Animal experiments on the mode of action of biguanide. 2. Studies with 5-methoxyindole-2-carbonic acid].
Losert W; Schillinger E; Kraaz W; Loge O; Jahn P
Arzneimittelforschung; 1972 Aug; 22(8):1413-9. PubMed ID: 4678403
[No Abstract] [Full Text] [Related]
38. [Comparison of the beta-cytotrophic effect of a new sulfonylurea derivative, glibornuride, and tolbutamide].
Bottermann P; Souvatzoglou A; Schwarz K; Rettig M
Klin Wochenschr; 1971 Jul; 49(13):769-70. PubMed ID: 4935073
[No Abstract] [Full Text] [Related]
39. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
[No Abstract] [Full Text] [Related]
40. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
Loubatières AL; Loubatieres-Mariani MM; Alric R; Ribes G; Sorial G; Tarasco A
Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
